Trial · NCT00968708
Adverse events1,464
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1,341 to 1,360 of 1,464
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Gamma-glutamyltransferase increased | Investigations | Placebo | 0 | 2,679 | |
| serious | Gamma-glutamyltransferase increased | Investigations | Alogliptin | 1 | 2,701 | |
| serious | Heart rate irregular | Investigations | Placebo | 1 | 2,679 | |
| serious | Heart rate irregular | Investigations | Alogliptin | 0 | 2,701 | |
| serious | International normalised ratio increased | Investigations | Placebo | 1 | 2,679 | |
| serious | International normalised ratio increased | Investigations | Alogliptin | 0 | 2,701 | |
| serious | Liver function test abnormal | Investigations | Placebo | 0 | 2,679 | |
| serious | Liver function test abnormal | Investigations | Alogliptin | 1 | 2,701 | |
| serious | Neutrophil count decreased | Investigations | Placebo | 0 | 2,679 | |
| serious | Neutrophil count decreased | Investigations | Alogliptin | 1 | 2,701 | |
| serious | Oxygen saturation decreased | Investigations | Placebo | 0 | 2,679 | |
| serious | Oxygen saturation decreased | Investigations | Alogliptin | 1 | 2,701 | |
| serious | Pancreatic enzymes increased | Investigations | Placebo | 1 | 2,679 | |
| serious | Pancreatic enzymes increased | Investigations | Alogliptin | 0 | 2,701 | |
| serious | Transaminases increased | Investigations | Placebo | 1 | 2,679 | |
| serious | Transaminases increased | Investigations | Alogliptin | 0 | 2,701 | |
| serious | Troponin increased | Investigations | Placebo | 1 | 2,679 | |
| serious | Troponin increased | Investigations | Alogliptin | 0 | 2,701 | |
| serious | Diabetic foot | Skin and subcutaneous tissue disorders | Placebo | 4 | 2,679 | |
| serious | Diabetic foot | Skin and subcutaneous tissue disorders | Alogliptin | 7 | 2,701 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00968708/events?page=68